Over 30 Years of Living Liver Donation in North America: Mortality Associated With Donation

Community Conversation on Next of Kin Research Authorization After Consent for Organ Donation

Ethical Obligations to Ineligible Living Donors

John Fluevog at the AST Town Hall

Older Donors and Older Recipients: Rethinking Risk, Benefit, and Access in Kidney Transplantation

Therapeutic needs in solid organ transplant recipients: The AST patient survey

2025 STAR Report on donor-derived cell-free DNA: appropriate and effective clinical utilization

Liver Viability Criteria During NRP

A New Frontier for Co-Stimulatory Blockade

Real-World Evaluation of an In-House dd-cfDNA Assay: A Single-Center Validation Study at TGH

Mechanisms and Treatment of Immune Complex GN and C3 GN

Molecular Monitoring in Transplant Oncology: cfDNA for MRD Detection & Immunosupression Optimization

ITAS and ITBS Adherence Measures: Clinical Pearls for Implementation and Optimization in Epic

Pregnancy Outcomes Using Assisted Reproductive Technology in Kidney Transplant Recipients

AST Interview with John Fluevog

AST Partnership with Fluevog Shoes

American Society of Transplantation Congressional Briefing - Unmet Needs in Immunosuppression

Serial Torque Teno Virus Monitoring to Assess Immunosuppression in Kidney Transplant Recipients

Assessing Deceased Donor Kidneys Through Post-Transplant Survival Prediction Algorithms

Ethical and Pragmatic Considerations in Early Liver Transplant for Alcohol-Related Liver Disease

Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children: A Randomized Clinical Trial

From Donor to Recipient: Navigating Donor-Derived Infections in Solid Organ Transplantation

Register Today - CEoT 2026

Hope, Healing, and New Life: Pregnancy After Transplant

Gender Inequity in Institutional Leadership Roles in US Academic Medical Centers

The Space Between Goodbye and Hello: A Donor Family and Recipient in Conversation

Individuals Who are Incarcerated as Transplant Living Donor Candidates: Considerations

Disparities in Medication Access in Solid-Organ Transplantation

CD38-Targeting Agents Along With Costimulation Blockade in the New Era of Desensitization

Indirect CD4+ T cell epitopes, transplant rejection, and donor-specific tolerance induction

The Use of Cannabis in Solid Organ Transplant Recipients

Semidirected living donors in Israel: Sociodemographic profile, religiosity, and social tolerance

A Blueprint for Career Growth & Development in the Transplant Field for Allied Health Professionals

The Countdown Is On: Don’t Miss The Transplant Event Of The Year! Register Now for WTC 2025.

OPTN Modernization and Emerging Policy Issues

Molecular Precision Testing: How RNA and AI May Guide Kidney Transplant Management

From Injury to Balance to Balance: Utilzing ddCFDNA & TTV in Kidney Transplant

CareDx Science and Innovation Theater

Innovation Approaches to CMV Management in Solid Organ Transplant: Transforming the Role of Cytogam

Navigating C3G in Transplantation: Addressing Unmet Needs and Managing Recurrence

Normothermic Regional Perfusion (NRP) and How DCD Donors Can Address the Organ Shortages

Clinical Conundrum: When cDNA & Biopsy Don't Agree

Living Donation and Pregnancy-Related Complications: State of the Evidence and Call To Action

BKPyV Serotype-Specific Antibody Responses in Blood Donors and Kidney Transplant Recipients

STAR Meeting: Session 5: Emerging Diagnostics: Donor Derived Cell Free DNA Update

STAR Meeting: Session 4: Epitopes, Eplets, and Transplantation: Quo Vadis?

STAR Meeting: Session 3: Harmonizing Efficacy of Antibody Reduction Therapy using Titers (HEARTT)

STAR Meeting: Session 2: Non-HLA Antibody: Updates and Next Steps

STAR Meeting: Session 1: The Potential Role of Innate Allorecognition

The Cost of Survival: Navigating the Financial Burden of Transplantation

Sexual bother and sexual activity before and after kidney transplantation

Virtual Crossmatches in Real Life-New CMS Guidelines

Using ChatGPT for Kidney Transplantation: Perceived information Quality by Race and Education Levels

Living Donor Circle of Excellence - A Public Policy Perspective

Living Donor Circle of Excellence - A Living Kidney Donor Perspective

Living Donor Circle of Excellence - A Transplant Center Perspective

Living Donor Circle of Excellence - An Organ Procurement Organization Perspective

Living Donor Circle of Excellence - A Transplant Nephrologist Perspective

Living Donor Circle of Excellence - An Executive Director Perspective

Living Donor Circle of Excellence - The Impact Policy Change Could Have